MET, the tyrosine kinase receptor for Hepatocyte Growth Factor (HGF), is frequently over-expressed in colon cancers with high metastatic tendency. We aimed at evaluating the role of its negative regulators, miR-1 and miR-199a*, and its transcriptional activator, the Metastasis Associated in Colon Cancer 1 (MACC1), in controlling MET expression in human colon cancer samples.
»
12/16/11